Health officials within the Trump administration are expected to miss the Sunday deadline set by the president for delivering new recommendations regarding childhood vaccinations, according to individuals familiar with the matter. The directive stems from an executive order signed in August by President Donald Trump alongside Health Secretary Robert F. Kennedy Jr., which mandated that officials produce a plan within 90 days.
The executive order instructed the Department of Health and Human Services (HHS) to evaluate several key areas of immunization policy. These include potentially splitting the combined measles, mumps, and rubella (MMR) vaccine into separate doses, assessing the "ideal timing" for childhood shots, investigating alternatives to aluminum components in certain vaccines, and enhancing safety monitoring protocols. During the signing of the order, Kennedy had publicly promised that the required plans would be delivered within the three-month window.
While an HHS spokesperson confirmed that the agency is actively working on implementing the president's mandate, they noted that the process requires meticulous scientific review. "The HHS Task Force on Safer Childhood Vaccines is working to strengthen vaccine safety research, improve transparency, and expand options for American families," the spokesperson stated. They added that the agency remains dedicated to fulfilling the president’s priorities through "gold standard science" and informed parental choice. Sources indicated that a draft of the plan has already been submitted to the White House for review.
The administrative effort coincides with a period of intense public health concern, as the United States navigates its largest measles outbreak in decades. The surge in cases poses a direct threat to the country’s long-held measles elimination status. The Pan American Health Organization is scheduled to convene next week to determine if the country has experienced sustained transmission for over 12 months, a development that would officially signal the loss of its elimination status.
According to data from the Centers for Disease Control and Prevention (CDC), there have been 5,182 confirmed measles cases across 45 states as of November 6. Fatalities have also been reported, including cases in Pennsylvania, New York, and Wisconsin. The federal government and the CDC are currently working with epidemiologists to establish a national definition for measles-related deaths, a process complicated by political disputes regarding the legitimacy of reported fatalities.
The task force responsible for developing these vaccine plans includes the directors of the National Institutes of Health, the CDC, and the commissioner of the Food and Drug Administration. This initiative is part of a broader, ongoing series of efforts by the Trump administration to modify the national childhood vaccine schedule. Previous steps have included a presidential memorandum in January and an executive order in May intended to align American immunization schedules with those of countries that recommend fewer vaccinations.
As the administration navigates these complex public health challenges, the debate over vaccine policy continues to draw significant attention. With MMR vaccines manufactured by companies including Merck & Co. Inc. and GSK Plc, the proposed changes are being closely watched by public health experts and families alike. The administration maintains that its primary goal through the task force is to improve safety research and offer more flexibility to parents, even as health officials struggle to meet the specific timeline established in August.
Comments